- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01148030
Impact of Pre-surgical Nasal Bacterial Reduction on Postoperative Surgical Site Infections / Standard Care Change
February 28, 2014 updated by: 3M
Patients presenting in the Emergency Department or admitted to the hospital with displaced hip fractures who require hemiarthroplasty or open reduction internal fixation or with spinal instability/fractures in need of urgent surgical intervention will receive treatment to reduce the number of microorganisms in their nose prior to surgery.
After surgery, the subjects will be observed for any surgical site infections.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Infection rate study.
Study Type
Observational
Enrollment (Actual)
333
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Diego, California, United States, 92123
- Sharp Memorial Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Emergent Hip Fractures
Description
Inclusion Criteria:
- Patients presenting in the Emergency Department or admitted to the hospital with displaced hip fractures who require hemiarthroplasty or open reduction internal fixation or with spinal instability/fractures in need of urgent surgical intervention will be enrolled in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Single
3M Skin and Nasal Antiseptic
|
Intra-nasal dosing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Surgical Site Infection
Time Frame: 1 year after surgery
|
1 year after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2010
Primary Completion (Actual)
July 1, 2012
Study Completion (Actual)
July 1, 2012
Study Registration Dates
First Submitted
June 18, 2010
First Submitted That Met QC Criteria
June 18, 2010
First Posted (Estimate)
June 22, 2010
Study Record Updates
Last Update Posted (Estimate)
March 3, 2014
Last Update Submitted That Met QC Criteria
February 28, 2014
Last Verified
February 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11319
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgical Site Infection
-
Gundersen Lutheran Medical FoundationGundersen Lutheran Health SystemCompletedSurgical Site Infection | Superficial Surgical Site Infection | Deep Surgical Site Infection | Organ/Space Surgical Site InfectionUnited States
-
Region SkaneVinnovaCompleted
-
MinaPharm PharmaceuticalsRecruitingSurgical Site InfectionsEgypt
-
Karolinska University HospitalStockholm South General HospitalRecruitingPostoperative Surgical Site InfectionSweden
-
Washington University School of MedicineCompleted
-
Population Health Research InstituteActive, not recruitingSurgical Site InfectionsCanada
-
University of RochesterSage Products, Inc.Completed
-
Singapore General HospitalNovem Healthcare Pte LtdTerminatedSuperficial Surgical Site InfectionSingapore
-
Halmstad County HospitalCompleted
-
Montefiore Medical CenterCompletedSurgical Site Infection Following Cesarean DeliveryUnited States
Clinical Trials on 3M Skin and Nasal Antiseptic
-
3MNew York UniversityCompletedSurgical Site InfectionUnited States
-
University of Iowa3MWithdrawnSARS-CoV-2 Acute Respiratory Disease
-
American Heart AssociationCompleted
-
3MUnited States Department of Defense; The University of Texas Health Science...Not yet recruitingSurgical Wound | Surgical Incision | Laceration | Trauma-related Wound
-
Tan Tock Seng HospitalTerminatedIncontinence-associated DermatitisSingapore
-
Imperial College LondonNovartis PharmaceuticalsCompleted
-
3MCompletedBacterial Recovery of Skin Flora Post-Product ApplicationUnited States
-
Medical University of ViennaRecruitingAllergy | Fungal AllergyAustria
-
Dartmouth-Hitchcock Medical CenterCompletedBreast Reconstruction | Breast Hypertrophy | Abdominal ElastosisUnited States